Nymox Pharmaceutical
NYMX
#9679
Rank
โ‚น1.54 B
Marketcap
Country
โ‚น16.88
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -โ‚น0.18 Billion

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -โ‚น0.56 Billion, an increase over its 2021 earnings that were of -โ‚น1.06 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -โ‚น0.18 Billion-68.18%
2022 -โ‚น0.56 Billion-47.71%
2021 -โ‚น1.06 Billion6.61%
2020 -โ‚น0.99 Billion-10.91%
2019 -โ‚น1.11 Billion24.24%
2018 -โ‚น0.9 Billion-20.03%
2017 -โ‚น1.12 Billion2.71%
2016 -โ‚น1.09 Billion-63.86%
2015 -โ‚น3.01 Billion674.44%
2014 -โ‚น0.39 Billion-6.11%
2013 -โ‚น0.42 Billion-35.66%
2012 -โ‚น0.65 Billion-20.76%
2011 -โ‚น0.82 Billion38.33%
2010 -โ‚น0.59 Billion35.59%
2009 -โ‚น0.44 Billion11.8%
2008 -โ‚น0.39 Billion-12.94%
2007 -โ‚น0.45 Billion8.85%
2006 -โ‚น0.41 Billion36.5%
2005 -โ‚น0.3 Billion-4.4%
2004 -โ‚น0.32 Billion-14.58%
2003 -โ‚น0.37 Billion
2001 -โ‚น0.27 Billion-20.54%
2000 -โ‚น0.34 Billion21.72%
1999 -โ‚น0.28 Billion-25.56%
1998 -โ‚น0.38 Billion101.3%
1997 -โ‚น0.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น572.17 B-313,751.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น102.32 Billion 55,985.15%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น93.95 B-51,603.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น856.87 B-469,813.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.552 T-851,326.28%๐Ÿ‡บ๐Ÿ‡ธ USA